Research Excellence Award
Hospital General Universitario Gregorio Maranon, Spain
| Javier David Lopez Morinigo | |
|---|---|
| Affiliation | Hospital General Universitario Gregorio Maranon |
| Country | Spain |
| Scopus ID | 34971723600 |
| Documents | 46 |
| Citations | 822 Citations by 671 documents |
| h-index | 20 |
| Subject Area | Data-informed Decision Making |
| Event | International Research Data Analysis Excellence & Awards |
| ORCID | 0000-0002-4264-2664 |
Javier David Lopez Morinigo is a psychiatrist and academic researcher affiliated with Hospital General Universitario Gregorio Maranon, Spain, whose scientific contributions have focused on psychosis, schizophrenia spectrum disorders, suicide prevention, metacognition, and mental health outcomes in clinical psychiatry. His research portfolio demonstrates a sustained commitment to evidence-based psychiatric investigation, interdisciplinary collaboration, and data-informed clinical decision-making in mental health sciences.[1]
His scholarly work spans clinical psychiatry, translational mental health research, digital psychiatry, and suicide risk assessment, with publications appearing in internationally indexed journals including Schizophrenia Research, European Psychiatry, Psychological Medicine, and The British Journal of Psychiatry. His investigations have contributed to the understanding of insight in psychosis, suicidal behaviour in first-episode psychosis, and the implementation of metacognitive interventions in schizophrenia care.[2][3]
Abstract
This academic recognition profile presents an overview of the scientific achievements, clinical research activities, and scholarly contributions of Javier David Lopez Morinigo in the field of psychiatry and mental health research. The profile highlights his work on schizophrenia spectrum disorders, suicide prevention, psychosis-related insight, metacognitive interventions, and digital mental health technologies. Through participation in multinational collaborations and competitive research projects funded by European and international institutions, Lopez Morinigo has contributed to advancing evidence-based psychiatric practice and data-driven approaches in mental healthcare systems.[4]
Keywords
Psychiatry; Schizophrenia; Psychosis; Suicide Prevention; Clinical Insight; Metacognition; Digital Mental Health; Data-informed Decision Making; Mental Health Research; Neuropsychiatry; Clinical Psychiatry; European Research Collaboration
Introduction
Javier David Lopez Morinigo completed his medical degree at the Universidade de Santiago de Compostela and subsequently specialized in psychiatry through the Spanish MIR training pathway. He later obtained a Doctor of Philosophy in Psychosis from King’s College London, where his doctoral research examined suicidal behaviour in early psychosis and the role of insight in schizophrenia spectrum disorders.[5]
His professional trajectory includes clinical and research appointments across Spain and the United Kingdom, including positions at South London and Maudsley NHS Foundation Trust, King’s College London, and Hospital General Universitario Gregorio Maranon. These roles facilitated the integration of clinical psychiatry with longitudinal psychiatric research and epidemiological analysis.[6]
Lopez Morinigo has been actively involved in collaborative European mental health projects focused on schizophrenia, psychosis, suicide prevention, and translational psychiatry. His participation in multinational studies reflects a commitment to international research cooperation and evidence synthesis in psychiatric medicine.[7]
Research Profile
The research profile of Lopez Morinigo encompasses clinical psychiatry, psychosis research, suicide epidemiology, metacognitive interventions, and psychiatric outcome assessment. His work frequently employs longitudinal cohort studies, systematic reviews, randomized controlled trials, and evidence-based clinical methodologies to examine psychiatric outcomes in schizophrenia and related disorders.[8]
He has participated in major European and international research initiatives including OPTiMiSE, EU-GEI, GAP, AGES-CM, and PRISM2. These projects investigate schizophrenia treatment optimization, gene-environment interactions, psychiatric stratification markers, and mental health determinants across populations.[9]
His academic record includes peer-reviewed publications, book chapters, clinical guideline contributions, and participation in scientific societies such as the European College of Neuropsychopharmacology and the Schizophrenia International Research Society. His publications have addressed clinically relevant themes including suicide risk, psychosis outcomes, metacognitive therapy, ecological momentary assessment, and digital psychiatric tools.[10]
Research Contributions
A major component of Lopez Morinigo’s scientific contribution concerns the relationship between insight and suicidal behaviour in schizophrenia and first-episode psychosis. His studies demonstrated the influence of depressive symptoms, prior suicide attempts, and metacognitive factors on suicidal risk trajectories among psychosis patients.[11][12]
His randomized clinical investigations into metacognitive training evaluated the effectiveness of psychoeducational and cognitive interventions for improving insight and clinical outcomes in schizophrenia. These studies contributed to the growing evidence base supporting metacognitive approaches in psychiatric rehabilitation and psychosis treatment.[13]
Lopez Morinigo has additionally contributed to digital psychiatry research through investigations into smartphone-based ecological momentary assessment tools and telehealth applications in psychiatric populations. His work addressed patient acceptability, digital engagement, and the integration of technological tools into mental healthcare systems.
Several of his publications have been incorporated into international schizophrenia treatment guidance documents and psychiatric clinical frameworks, including references within established psychiatric prescribing and treatment guidance literature.
Publications
Selected peer-reviewed publications authored or co-authored by Javier David Lopez Morinigo include:
- Can metacognitive interventions improve insight in schizophrenia spectrum disorders? A systematic review and meta-analysis, Psychological Medicine (2020). DOI: 10.1017/S0033291720003384.[1]
- Use of Ecological Momentary Assessment Through a Passive Smartphone-Based App (eB2) by Patients With Schizophrenia: Acceptability Study, Journal of Medical Internet Research (2021). DOI: 10.2196/26548.[7]
- Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs, Pharmacopsychiatry (2022). DOI: 10.1055/a-1854-0185.[8]
- Is too much insight bad for you?, The British Journal of Psychiatry (2024). DOI: 10.1192/bjp.2024.173.[9]
- Mental health status of the European population and its determinants: a cross-national comparison study, European Psychiatry (2025). DOI: 10.1192/j.eurpsy.2025.2449.[10]
Research Impact
The scientific impact of Lopez Morinigo’s work is reflected through indexed publications, international collaborations, and citation performance across psychiatric and mental health literature databases. His scholarly metrics include an h-index of 20 and more than 800 citations indexed through Scopus-related records, alongside a substantial number of publications in internationally recognized psychiatric journals.
His research has contributed to broader understanding of suicide prevention strategies, psychosis prognosis, metacognitive treatment mechanisms, and digital mental healthcare implementation. The translational relevance of his work supports both clinical psychiatry and mental health policy development in European healthcare contexts.
In addition to publication activity, Lopez Morinigo has participated in multiple competitively funded research initiatives supported by the European Commission, British Medical Association, and international collaborative research consortia. These projects demonstrate sustained research leadership and interdisciplinary engagement in psychiatric sciences.
Award Suitability
Javier David Lopez Morinigo’s profile aligns with the objectives of the International Research Data Analysis Excellence & Awards through his integration of clinical psychiatry, data-driven psychiatric evaluation, and evidence-based decision-making methodologies. His contributions to psychosis research, suicide prevention, and metacognitive interventions demonstrate the application of analytical approaches to complex psychiatric outcomes.
His leadership in international collaborations, systematic reviews, randomized trials, and longitudinal psychiatric investigations reflects sustained academic productivity and methodological rigor. The interdisciplinary nature of his work, combining psychiatry, epidemiology, digital assessment technologies, and healthcare analytics, further supports his suitability for recognition within international academic award frameworks.
Conclusion
Javier David Lopez Morinigo has established a recognized academic and clinical research profile within psychiatry and mental health sciences. His investigations into schizophrenia, suicidal behaviour, insight in psychosis, and metacognitive interventions have contributed to evidence-based psychiatric knowledge and international collaborative mental health research. Through scholarly publications, competitive research funding, clinical leadership, and interdisciplinary collaborations, he has demonstrated sustained engagement with data-informed psychiatric investigation and translational mental healthcare research.
External Links
- ORCID Profile
- Scopus Author Profile
- Representative DOI Publication
- International Research Data Analysis Excellence & Awards
References
- Lopez-Morinigo, J. D., et al. (2020). Can metacognitive interventions improve insight in schizophrenia spectrum disorders? A systematic review and meta-analysis. Psychological Medicine.
https://doi.org/10.1017/S0033291720003384
- Lopez-Morinigo, J. D., et al. (2018). Insight and risk of suicidal behaviour in two first-episode psychosis cohorts. Schizophrenia Research.
https://doi.org/10.1016/j.schres.2018.09.016 - Lopez-Morinigo, J. D., et al. (2023). A pilot randomized controlled trial comparing metacognitive training to psychoeducation in schizophrenia. Schizophrenia.
https://doi.org/10.1038/s41537-022-00316-x
- Lopez-Morinigo, J. D., et al. (2011). Insight in schizophrenia and risk of suicide: a systematic update. Comprehensive Psychiatry.
https://doi.org/10.1016/j.comppsych.2011.05.015
- Ayesa Arriola, R., et al. (2018). The dynamic relationship between insight and suicidal behavior in first episode psychosis patients. European Neuropsychopharmacology.
https://doi.org/10.1016/j.euroneuro.2018.05.005
- Lopez-Morinigo, J. D., et al. (2020). Study protocol of a randomised clinical trial testing whether metacognitive training can improve insight and clinical outcomes in schizophrenia. BMC Psychiatry.DOI:
https://doi.org/10.1186/s12888-020-2431-x
- Lopez-Morinigo, J. D., et al. (2021). Use of Ecological Momentary Assessment Through a Passive Smartphone-Based App (eB2) by Patients With Schizophrenia: Acceptability Study. Journal of Medical Internet Research.
https://doi.org/10.2196/26548
- Lopez-Morinigo, J. D., Leucht, S., & Arango, C. (2022). Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs. Pharmacopsychiatry.
https://doi.org/10.1055/a-1854-0185
- Lopez-Morinigo, J. D., & David, A. S. (2024). Is too much insight bad for you? The British Journal of Psychiatry.
https://doi.org/10.1192/bjp.2024.173
- Arango, C., Dom, G., Fiorillo, A., & Lopez-Morinigo, J. D. (2025). Mental health status of the European population and its determinants: a cross-national comparison study. European Psychiatry.
https://doi.org/10.1192/j.eurpsy.2025.2449
- Elsevier. (2026). Scopus author details: Javier David Lopez Morinigo, Author ID 34971723600.
https://www.scopus.com/authid/detail.uri?authorId=34971723600
- Sainz-Fuertes, R., et al. (2021). COVID-19 and mental health: A review and the role of telehealth and virtual reality. Digital Medicine.
https://doi.org/10.4103/digm.digm_22_20
- International Research Data Analysis Excellence & Awards. (2026). Award criteria and evaluation framework. https://researchdataanalysis.com/